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Abstract Stimulated neutrophils exhibit coordinated sinusoidal 
oscillations in filamentous actin content and cellular shape. We 
investigated the effect of inhibition of the small G protein Rho on 
neutrophil actin polymerization, shape changes and oscillations 
using a genetically engineered toxin that enters cells and selec- 
tively ADP-ribosylates endogenous Rho. This treatment in- 
creased the amplitudes and frequencies of shape oscillations and 
duration of the oscillating transient. However, it had no effect on 
the initial actin polymerization and shape changes induced by 
N-formyl-Met-Len-Phe. Regulation of these oscillations may be 
important for the control of neutrophil motility. 
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1. Introduction 
Actin reorganization plays a central role in mediating neutro- 
phil shape changes [1,2]. The signal transduction pathway for 
actin polymerization depends on agonist-receptor binding [1,2] 
and activation of a plasma membrane-located heterotrimeric G 
protein [3]. However, the events downstream of receptor-G 
protein interaction are a matter of debate. It was shown in 
human neutrophils that the transient increase in filamentous 
actin (F-actin) is parallelled by a rise in intracellular phosphat- 
idylinositol 3,4,5-trisphosphate [4].The authors concluded that 
stimulation activates phosphatidylinositol 3-kinase (PI 3-ki- 
nase), thereby generating phosphatidylinositol 3,4,5-tris- 
phosphate which they suggested is an initiator of actin polym- 
erization. 
PI 3-kinase is inhibited in vivo by wortmannin with an IC~o 
of 5 nM [5] (wortmannin also inhibits myosin light chain kinase 
[6] and mitogen-activated protein kinase [7], but this requires 
40-200 x higher concentrations). Neutrophil pretreatment 
with wortmannin and certain analogs causes inusoidal oscilla- 
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tions in F-actin content and whole-cell light scattering having 
a period of 8-10 s [8,9]. The scattering oscillations apparently 
arise from cellular shape changes reflecting periodic actin po- 
lymerization-driven protrusion and retraction of weakly scat- 
tering lamellipods [8,10] and probably constitute a fundamental 
cellular esponse related to the amoeboid-like crawling motions 
of stimulated neutrophils [9]. 
Agonist-induced PI 3-kinase activity is coupled with stimula- 
tion of the small G protein Rho in Swiss 3T3 cells [11] as well 
as in human platelets, where Rho associates with the cytoskel- 
eton upon stimulation [12,13]. Microinjection of Rho causes 
formation of actin stress fibers emanating from focal adhesions 
in Swiss 3T3 [14] and Vero cells [15], but the response is pre- 
vented by ADP-ribosylation of endogenous Rho. We investi- 
gated whether Rho plays a role in the F-actin-coupled oscilla- 
tions in human neutrophil shape described earlier [8]. Intracel- 
lular Rho was inhibited by means of a genetically engineered 
chimeric toxin C3B [15] containing a membrane-translocating 
subunit derived from diphtheria toxin and a functional subunit 
(exoenzyme C3 from Clostridium botulinum) which selectively 
ADP-ribosylates and inactivates RhoA, B and C [15-17]. 
2. Experimental 
2.1. Materials 
[nP]NAD (30 Ci/mmol) was purchased from NEN-Du Pont de Ne- 
mours, Dreieich, Germany; all other chemicals were obtained as de- 
scribed [9]. Neutrophils were isolated from buffy coats of single donors 
and suspended in test buffer [9]. 
2.2. ADP-ribosylation 
Chimeric toxin C3B was prepared by genetic fusion of the exoenzyme 
C3 gene (coding for the catalytic subunit) to DNA coding for diphtheria 
toxin (the membrane-translocating subunit) [15]. Neutrophils (1- 
10 x 107/ml) were incubated with C3B (4/zg/ml, ~0.1/zM) for 100 rain 
at 37°C. 
In vitro ADP-ribosylation was performed with postnuclear lysates 
[15]. Eight million cells incubated with or without C3B were washed 
once with ice-cold test buffer, resuspended in 350/.tl ice-cold lysis buffer 
(2 mM MgC1J0.1 mM phenyl-methyl-sulfonyl-fluoride/10 pg/ml 
leupeptine/25 mM triethanolamine-HC1, pH 7.5), sonicated on ice using 
a probe sonicator and five 15-s pulses (Sonifier, Cell Disruptor B-30, 
Branson Sonic Power, Danbury, CT) and centrifuged for 10 min at 
2000 x g and 4°C. The supernatant was used as postnuclear lysate: an 
aliquot containing 10/lg protein (determined using the protein assay 
reagent kit from Pierce, Rockford, IL) was incubated with 2.5 ¢tM 
[32p]NAD (20,000 dprn/pmol), 2.5 mM AMP and C3B (4 pg/ml) for 30 
min at 37°C. The reaction was stopped by adding 5/11 sample buffer 
and incubating for 3 rain at 90°C. An SDS-PAGE was performed, the 
gel was stained with Coomassie blue, dried and exposed in a phosphori- 
mager (Molecular Dynamics, Sevenoaks, UK). A broad range protein 
standard (Bio-Rad, Hercules, CA) was used. 
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2.3. Measurements of F-actin and shape change 
Total F-actin was determined using the method of Howard and 
Oresajo [18]. One million neutrophils were incubated for 100 min at 
37°C in the presence or absence of C3B, stimulated with 10 nM fMLP 
for 10 s, fixed for 15 min at 37°C with 3.7% formaldehyde supple- 
mented with 2 mM EDTA (to prevent cellular aggregation) and then 
permeabilized (67 pg lysophosphatidylcholine/ml) and stained with 0.33 
/.tM Rhodamine phalloidin for 15 min at room temperature. Five thou- 
sand cells/sample were analysed in a Coulter Epics Profile II flow 
cytometer (Coulter Corporation, Hialeah, FL). 
Neutrophil shape changes were assayed in suspensions of 8 × 105 
cells/ml using laser turbidimetry as described [9]. 
3. Results and discussion 
3.1. ADP-ribosylation fRho by C3B 
To examine whether the chimeric toxin C3B had entered the 
neutrophils and effectively ADP-ribosylated cellular Rho, in 
vitro ADP-ribosylation using [32p]NAD was carried out on 
postnuclear lysates of untreated or C3B-pretreated neutrophils. 
Thereby, all C3B substrate which had not been previously 
ADP-ribosylated in vivo (especially in untreated control cells) 
was radiolabelled in vitro and could thus be autoradiographi- 
cally assayed. Postnuclear lysate of cells which had been pre- 
treated with C3B (4/tg/ml) for 100 min at 37°C contained no 
detectable substrate available for ADP-ribosylation with 
[32p]NAD (Fig. 1, lane 1), whereas control lysate (from cells 
incubated with test buffer at 37°C) yielded a [32p]ADP-ribosyl- 
ated band at Mr ~23 kDa (Fig. 1, lane 2) corresponding to 
the previously reported Mr of exoenzyme C3 substrate 
[11,12,17,19]. These results indicate that endogenous Rho is 
effectively inactivated in vivo by C3B under the conditions we 
used. 
3.2. Actin polymerization a d shape changes 
Inactivation of Rho by C3B-mediated ADP-ribosylation did 
not inhibit the fMLP-induced actin polymerization sampled 
l0 s following stimulus addition (Fig. 2) or alter the time-de- 
pendent shape-sensitive scattering changes (Fig. 3). The results 
with F-actin are similar to those obtained by Koch et al. [20], 
who found that electropermeabilization of exoenzyme C3-1ike 
transferase from Clostridium limosum into HL-60 cells ADP- 
ribosylated Rho without inhibiting fMLP-induced actin polym- 
erization. 
Neutrophil shape oscillations dying out 40 60 s after agonist 
addition are routinely enabled by specific manipulations which 
inhibit PI 3-kinase activity, i.e. pretreatment with 1 /IM 
Table 
Light scattering oscillation frequencies of C3B-treated and control neu- 
trophils stimulated with fMLP 
Treatment Oscillation frequency in Hz and significance P for: 
Extinction P 90 ° scattering P 
C3B 0,122 + 0,014 (8) - 0.122 + 0,013 (8) - 
Control 0.106 + 0,013 (7) 0.04 0.108 + 0,010 (10) 0.02 
Power spectral density estimates. Neutrophils treated in the presence 
or absence (control) of C3B for 100 min at 37°C and 10 min preincu- 
bated with 1/.tM HWT were stimulated with 10 nM fMLP. Table values 
are mean + S.D.; parentheses nclose the number of independent exper- 
iments. P is the probability that the oscillation frequency obtained in 
both treatments i the same (Student's t-test). 
1 2 
66 kD - "  
45 kD - - "  
31 kD - - "  
21 kD - - "  
14 kD -"" 
RHO 
¢aO O 
O 
Fig. 1. The chimeric toxin C3B ADP-ribosylates Rho within neutro- 
phils. Postnuclear lysates of cells treated with (lane 1) or without (con- 
trol, lane 2) C3B were subjected to in vitro ADP-ribosylation i the 
presence of [32p]NAD. SDS-PAGE of the lysates was performed and 
the gel was dried and analysed using a phosphorimager. The arrows 
show the position of the marker proteins tained with Coomassie blue 
in the same gel. Data of one experiment are shown; similar esults were 
obtained in two experiments u ing neutrophils from different donors. 
17-hydroxywortmannin (HWT) or wortmannin [5,8,9] or pre- 
stimulation with an agonist [9,21]. Activation of certain PI 
3-kinases is affected by ADP-ribosylation of Rho in other cell 
types [11 13]. Therefore, we speculated that Rho inhibtion 
could also enable neutrophil oscillations. Fig. 3 shows that 
ADP-ribosylation of Rho by itself is not sufficient o enable 
fMLP-provoked oscillations. However, when treatment with 
C3B is used in conjunction with HWT, the oscillations are 
markedly enhanced (Fig. 4, Table 1) under conditions where PI 
3-kinase activity is completely prevented [5]. In HWT-preincu- 
bated cells, ADP-ribosylation of Rho-enhanced amplitude and 
duration of scattering-detected shape oscillations (Fig. 4); addi- 
tionally, oscillation frequencies in these cells were higher than 
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Fig. 2. Effect of Rho ADP-ribosylation on the basal and fMLP-stimu- 
lated F-actin content. Cells preincubated in the presence or absence of 
C3B were stimulated with fMLP (10 nM) for 10 s. Cells were fixed, 
stained with Rhodamine phalloidin and analysed for total E-actin in a 
flow cytometer. Data are expressed as fluorescence intensity/cell (fluo- 
rescence channel number) vs. cell number. 
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l 'ig. 3. Scattering-detected neutrophil shape changes in the presence and 
bsence of Rho ADP-ribosylation (% of initial). Cells treated without 
r with C3B (100 rain at 37°C) were stimulated with 10 nM fMLP at 
~me 0 (arrow) and relative changes in 90 ° light scattering (top) and 
xtinction (bottom) were measured. Similar esults were found in four 
xperiments using cells from different donors. 
hose of control cells (Table 1). Thus, exposure of human neu- 
rophils to HWT unmasks a pathway which regulates hape 
~scillations and is sensitive to modulation by Rho. 
Agonist-induced changes in light scattering by suspended 
leutrophils reflect, in part, the generation of thin, veil-like 
amellipods [8,10,22]. In contrast o morphological lterations 
n suspension, neutrophil migration over a substrate depends 
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Fig. 4. Effect of Rho ADP-ribosylation on neutrophil shape oscilla- 
tions. Neutrophils were pretreated with or without C3B for 100 min and 
with I pM HWT for 10 rain; fMLP (10 nM) was added at time 0 (arrow) 
and relative changes in 90 ° light scattering (top) and extinction (bot- 
tom) were recorded. The data shown (% of initial) are representative 
for eight independent experiments. 
upon reversible formation of adhesion sites and is blocked by 
exoenzyme C3-mediated ADP-ribosylation [19]. We suspect 
that Rho inhibtion prevents neutrophil translocation over a 
substrate by interfering with the formation of adhesion sites. 
The finding that Rho inactivation enhances cattering-de- 
tected shape oscillations (in the presence of HWT) brings up 
questions about he regulatory mechanism involved in the oscil- 
lations. Existing evidence suggests that actin polymerization/ 
depolymerization cycles are responsible lbr lamellipod forma- 
tion and remodelling [8]. Two different F-actin pools exist in 
human neutrophils: a gelsolin-rich, labile F-actin pool and a 
stable F-actin pool [23,24]. Net F-actin growth induced by 
fMLP results from simultaneous addition of actin monomers 
and labile F-actin to the stable F-actin pool [25]. It is tempting 
to speculate that blocking Rho prior to stimulation partially 
shifts stable F-actin into the labile F-actin pool, thus enhancing 
agonist-induced actin polymerization and lamellipod forma- 
tion. Time-resolved measurements of the labile F-actin and 
globular actin pools in C3B-treated cells, which could clarify 
this speculation, are not yet available. However, in HL-60 cells 
Rho inhibition decreases resting cell F-actin and enhances F- 
actin polymerization stimulated by fMLP in agreement with 
this hypothesis [20]. 
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